Abiopharma

🔍 Slater Jennifer Lynn (Executive)

Company: STRATTEC SECURITY CORP (STRT)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 9,296 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 59,695.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 9,296 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | Expires: 2029-09-29 | equity_swap_involved: false | shares_owned_after: 36,344.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Grant of shares of restricted stock which vest pro rata over three years on each anniversary of the grant date (i.e., one-third vest on each of September 1, 2027, September 1, 2028 and September 1, 2029).
• F2: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's EBITDA percentage over a three-year performance period ending July 1, 2029, subject to a modifier based on relative total shareholder return.